Kathmere Capital Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.57M | Sell |
19,802
-149
| -0.7% | -$11.8K | 0.12% | 114 |
|
|
2025
Q1 | $1.79M | Sell |
19,951
-523
| -3% | -$46.9K | 0.15% | 97 |
|
|
2024
Q4 | $2.04M | Sell |
20,474
-438
| -2% | -$43.6K | 0.18% | 85 |
|
|
2024
Q3 | $2.37M | Buy |
20,912
+305
| +1% | +$34.6K | 0.22% | 73 |
|
|
2024
Q2 | $2.55M | Buy |
20,607
+1,062
| +5% | +$131K | 0.27% | 62 |
|
|
2024
Q1 | $2.58M | Hold |
19,545
| – | – | 0.29% | 57 |
|
|
2023
Q4 | $2.13M | Buy |
19,545
+273
| +1% | +$29.8K | 0.28% | 56 |
|
|
2023
Q3 | $1.98M | Buy |
19,272
+1,810
| +10% | +$186K | 0.29% | 60 |
|
|
2023
Q2 | $2.01M | Buy |
17,462
+1,494
| +9% | +$172K | 0.31% | 52 |
|
|
2023
Q1 | $1.7M | Sell |
15,968
-854
| -5% | -$90.9K | 0.28% | 54 |
|
|
2022
Q4 | $1.87M | Buy |
16,822
+868
| +5% | +$96.3K | 0.33% | 51 |
|
|
2022
Q3 | $1.37M | Buy |
15,954
+2,372
| +17% | +$204K | 0.27% | 54 |
|
|
2022
Q2 | $1.24M | Buy |
13,582
+1,136
| +9% | +$104K | 0.23% | 48 |
|
|
2022
Q1 | $1.02M | Buy |
12,446
+2,932
| +31% | +$241K | 0.17% | 53 |
|
|
2021
Q4 | $729K | Sell |
9,514
-1,216
| -11% | -$93.2K | 0.13% | 61 |
|
|
2021
Q3 | $806K | Sell |
10,730
-293
| -3% | -$22K | 0.15% | 59 |
|
|
2021
Q2 | $857K | Buy |
11,023
+428
| +4% | +$33.3K | 0.16% | 55 |
|
|
2021
Q1 | $779K | Buy |
10,595
+6,208
| +142% | +$456K | 0.15% | 56 |
|
|
2020
Q4 | $342K | Buy |
4,387
+457
| +12% | +$35.6K | 0.07% | 83 |
|
|
2020
Q3 | $311K | Buy |
+3,930
| New | +$311K | 0.08% | 75 |
|